Huirong Pan

1.3k total citations
24 papers, 331 citations indexed

About

Huirong Pan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Huirong Pan has authored 24 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Hepatology and 8 papers in Infectious Diseases. Recurrent topics in Huirong Pan's work include Cervical Cancer and HPV Research (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). Huirong Pan is often cited by papers focused on Cervical Cancer and HPV Research (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). Huirong Pan collaborates with scholars based in China, Italy and India. Huirong Pan's co-authors include Jun Zhang, Ningshao Xia, Shaowei Li, Minxi Wei, Zhijie Lin, Ting Wu, Shoujie Huang, Qinjian Zhao, Ying Gu and Xiao Zhang and has published in prestigious journals such as Protein Science, Vaccine and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Huirong Pan

23 papers receiving 326 citations

Peers

Huirong Pan
Minxi Wei China
Cyril Masante France
Abraham J. Kandathil United States
Aldo Barrera Chile
Teresa Aydillo United States
Lorena Sánchez-Felipe Belgium
В. В. Зверев Russia
Nami Konomi Japan
N Bannert Germany
Minxi Wei China
Huirong Pan
Citations per year, relative to Huirong Pan Huirong Pan (= 1×) peers Minxi Wei

Countries citing papers authored by Huirong Pan

Since Specialization
Citations

This map shows the geographic impact of Huirong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huirong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huirong Pan more than expected).

Fields of papers citing papers by Huirong Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huirong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huirong Pan. The network helps show where Huirong Pan may publish in the future.

Co-authorship network of co-authors of Huirong Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Huirong Pan. A scholar is included among the top collaborators of Huirong Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huirong Pan. Huirong Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Li, Qiufen Zhang, Jiaye Liu, et al.. (2025). Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China. Human Vaccines & Immunotherapeutics. 21(1). 2448882–2448882. 1 indexed citations
2.
Zhuang, Chunlan, Xiaowen Hu, Qi Chen, et al.. (2023). Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial. Emerging Microbes & Infections. 12(1). 2185456–2185456. 12 indexed citations
3.
Mo, Zhaojun, Sheng Wei, Qi Chen, et al.. (2022). Safety and immunogenicity of an Escherichia coli -produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial. Human Vaccines & Immunotherapeutics. 18(6). 2092363–2092363. 4 indexed citations
4.
Chen, Qi, Hui Zhao, Xingmei Yao, et al.. (2020). Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages. Vaccine. 38(39). 6096–6102. 8 indexed citations
5.
Huang, Xiaofen, Yike Li, Zhijie Lin, et al.. (2020). Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal. Journal of Pharmaceutical Analysis. 11(5). 617–627. 5 indexed citations
6.
Li, Juan, Zhijie Lin, Hui Zhao, et al.. (2020). Immunogenicity of an Escherichia coli -produced bivalent human papillomavirus vaccine under different vaccination intervals. Human Vaccines & Immunotherapeutics. 16(7). 1630–1635. 2 indexed citations
7.
Yin, Xiaochen, Xin Wang, Zhigang Zhang, et al.. (2019). Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods. Journal of Pharmaceutical and Biomedical Analysis. 177. 112880–112880. 9 indexed citations
8.
Chen, Zhiping, Shenyu Wang, Huirong Pan, et al.. (2019). Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years. Vaccine. 37(32). 4581–4586. 24 indexed citations
9.
Chen, Siyi, Xiaofen Huang, Yike Li, et al.. (2019). Altered antigenicity and immunogenicity of human papillomavirus virus-like particles in the presence of thimerosal. European Journal of Pharmaceutics and Biopharmaceutics. 141. 221–231. 12 indexed citations
10.
Zhang, Zhigang, Lu Cao, Xin Wang, et al.. (2019). Simultaneous In Situ Visualization and Quantitation of Dual Antigens Adsorbed on Adjuvants Using High Content Analysis. Nanomedicine. 14(19). 2535–2548. 5 indexed citations
11.
12.
Wei, Minxi, Daning Wang, Zhihai Li, et al.. (2018). N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro. Emerging Microbes & Infections. 7(1). 1–12. 18 indexed citations
13.
Gu, Ying, Minxi Wei, Daning Wang, et al.. (2017). Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccine. Vaccine. 35(35). 4637–4645. 28 indexed citations
14.
Pan, Huirong, Zhihai Li, Jin Wang, et al.. (2017). Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity. Vaccine. 35(24). 3222–3231. 6 indexed citations
15.
16.
Zhang, Xiao, Minxi Wei, Huirong Pan, et al.. (2014). Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin®. Vaccine. 32(32). 4039–4050. 69 indexed citations
17.
Zhao, Hui, Zhijie Lin, Shoujie Huang, et al.. (2014). Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination. Human Vaccines & Immunotherapeutics. 10(3). 740–746. 22 indexed citations
18.
Yang, Chunyan, Huirong Pan, Minxi Wei, et al.. (2012). Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts. Protein Science. 22(3). 314–326. 18 indexed citations
19.
Pan, Huirong, Shaowei Li, Bo Liu, et al.. (2009). Production of human papillomavirus type 6 virus-like particles and detection of its neutralizing antibodies. Zhonghua weishengwuxue he mianyixue zazhi. 29(1). 71–76. 2 indexed citations
20.
Yang, Kunyu, Shaowei Li, Jiannan Zhang, et al.. (2009). Expression and purification of soluble HIV-1 envelope glycoprotein gp160 mutant from Saccharomyces cerevisiae. Journal of Bioscience and Bioengineering. 108(1). 5–10. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minxi Wei Breakdown of academic impact, for papers by Cyril Masante Breakdown of academic impact, for papers by Abraham J. Kandathil Breakdown of academic impact, for papers by Aldo Barrera Breakdown of academic impact, for papers by Teresa Aydillo Breakdown of academic impact, for papers by Lorena Sánchez-Felipe Breakdown of academic impact, for papers by В. В. Зверев Breakdown of academic impact, for papers by Nami Konomi Breakdown of academic impact, for papers by N Bannert
Rankless by CCL
2026